| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹0.3 -64.7% | 19,3754.16% |
| 2,3250% | ₹136.55 0% | 820 | ₹0.65 8.33% | 2,3250% |
| 4,650100% | ₹137.5 14.39% | 840 | ₹0.3 -25% | 44,950-6.45% |
| 7750% | ₹130 0% | 850 | ₹0.6 0% | 20,9250% |
| - | - | 870 | ₹1 0% | 4,6500% |
| - | - | 880 | ₹1.15 4.54% | 30,2252.63% |
| 7750% | ₹78.75 0% | 890 | ₹1.5 0% | 35,6500% |
| 13,1756.25% | ₹66.75 -20.05% | 900 | ₹2.4 23.07% | 1,26,3250.61% |
| 3,1000% | ₹60.25 0% | 910 | ₹3.05 52.5% | 44,1755.55% |
| 20,9253.84% | ₹49 -15.87% | 920 | ₹4.35 27.94% | 72,075-4.12% |
| 82,1500% | ₹46.25 0% | 930 | ₹6.35 30.92% | 65,875-2.29% |
| 98,4250% | ₹43.05 0% | 940 | ₹8.6 32.3% | 1,58,1001.49% |
| 1,50,3504.30% | ₹25.7 -27.09% | 950 | ₹11.4 28.81% | 1,27,87522.22% |
| 1,84,4505.77% | ₹19.35 -33.16% | 960 | ₹15.9 33.61% | 1,96,075-0.78% |
| 1,70,50030.95% | ₹14.3 -36.58% | 970 | ₹21.1 32.28% | 1,33,3000% |
| 4,48,7251.22% | ₹10.5 -39.48% | 980 | ₹26.8 29.15% | 98,425-13.60% |
| 2,77,4505.29% | ₹7.6 -41.08% | 990 | ₹33.55 27.8% | 47,275-4.68% |
| 6,32,400-10.72% | ₹5.4 -43.75% | 1,000 | ₹40.9 23.75% | 1,34,850-1.13% |
| 2,10,800-0.36% | ₹3.85 -44.2% | 1,010 | ₹41.05 0% | 8,5250% |
| 1,86,00013.20% | ₹2.6 -47.47% | 1,020 | - | - |
| 99,2009.40% | ₹1.85 -47.14% | 1,030 | - | - |
| 89,9002.65% | ₹1.45 -38.29% | 1,040 | ₹66 0% | 1,5500% |
| 90,6756.36% | ₹1 -41.17% | 1,050 | - | - |
| 2,02,2750% | ₹0.7 -36.36% | 1,060 | - | - |
| 7750% | ₹1 0% | 1,070 | - | - |
| 20,1500% | ₹0.45 -43.75% | 1,080 | ₹125.8 0% | 3,1000% |
| 1,55,0000% | ₹0.4 0% | 1,100 | ₹135.85 0% | 1,5500% |
| 13,9500% | ₹0.75 -6.25% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.